Epitopoietic Research Corporation (ERC-Worldwide), is a clinical stage emerging biopharmaceutical company developing a safe, highly effective approach for the treatment of cancer, particularly cancers of the brain as well as emerging infectious diseases such as SARS-Cov-2, Ebola and other viruses. ERC has built a network of leading clinicians in several countries in the world, among others in the US and Europe to propel its im...
Epitopoietic Research Corporation (ERC-Worldwide), is a clinical stage emerging biopharmaceutical company developing a safe, highly effective approach for the treatment of cancer, particularly cancers of the brain as well as emerging infectious diseases such as SARS-Cov-2, Ebola and other viruses. ERC has built a network of leading clinicians in several countries in the world, among others in the US and Europe to propel its immunotherapies through clinical development and to market. ERC’s regimen of therapeutic vaccines has shown early promise in patients suffering from recurrent Glioblastoma multiforme (GBM), the deadliest of brain cancers
Sponsored Ad
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.